Though optimistic, speakers at the recent LSX World Congress in London, UK, recognised that recent turbulence in the wake of ...

Good morning, Boston, and happy Friday. Here are the five things you need to know in local business news to start your busy day, including Moderna's cost cuts, "misunderstood" Wayfair, the highest ...

Universities and companies that turn discoveries into medicines in Seattle have searched for “safe harbor” from the White ...

Among three Korean biotech companies slated to sell shares on the Korea Exchange this month, Immuneoncia Therapeutics Inc. is ...

After a decade of significant challenges, biotech's long-term sustainability depends on making fundamental changes to its traditional business model. A commonly held perception in the biotech ...

Cancer biotech BeyondSpring has launched on the Nasdaq stock exchange – in an IPO that can only be described as distinctly underwhelming. The company is developing the cancer drug plinabulin ...

Over the past few weeks, a new crop of blank-check companies have announced plans to merge with target companies in areas ...

Just three years ago, Circassia was riding high, raising £200 million ($285 million) from its initial public offering (IPO), making it the most successful European biotech stock launch ever.

Hong Kong’s economic vitality has long been underpinned by the buoyancy of its capital markets. The city’s bourse was the ...

About seven months ago, a dividend investor shared his monthly dividend income details and portfolio on r/Dividends — a ...